Planegg, Germany · Founded 2010 · Privately Held (backing)
Developer of drugs through nanoscience designed to offer patient outcomes. Leon Nanodrugs is based in Planegg, Germany and was founded in 2010. Its last reported valuation was $71 million in Jul 2015. It has raised $20.5 million.
Last reported valuation
$71.0M
Oct 2026
Priced at
—
Total raised
$20.5M
Last round
—
Cap table — not yet on record
Leon Nanodrugs's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Leon Nanodrugs with a free account
·The complete investor list: 11 names
·Watch Leon Nanodrugs: the Monday email on marks, rounds and moves
